Re-Vana Therapeutics is a 2016 start-up based on a technology developed at Queen’s University Belfast (QUB), Northern Ireland, UK. QUB has recently been recognized as the No. 1 university in the UK for their capacity to commercialize research*. The novel concept of photocrosslinking for ocular drug delivery was developed by Dr. Raj Thakur and his team. Re-Vana is developing photocrosslinked technologies for delivery of a wid...
Re-Vana Therapeutics is a 2016 start-up based on a technology developed at Queen’s University Belfast (QUB), Northern Ireland, UK. QUB has recently been recognized as the No. 1 university in the UK for their capacity to commercialize research*. The novel concept of photocrosslinking for ocular drug delivery was developed by Dr. Raj Thakur and his team. Re-Vana is developing photocrosslinked technologies for delivery of a wide range of therapeutics that may dramatically extend the time between intravitreal, topical or other injectable routes of administrations to the eye.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.